# Palonosetron

NDC: 68001-355
Generic name: Palonosetron
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180530

FDA application: ANDA201533

## Active ingredients

- PALONOSETRON HYDROCHLORIDE: .05 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-355"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-355
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee6f6f94-1ca7-481e-9909-b19ae64e80c2